NCT01580202View on ClinicalTrials.gov

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
MalignancyHepatitis B
Interventions
DRUG

Entecavir

Entecavir 0.5mg daily per os

DRUG

Lamivudine

lamivudine 100mg daily per os

Trial Locations (5)

14584

Soon Chun Hyang University Bucheon Hospital, Bucheon-si

410-769

National Cancer Center, Korea, Goyang-si

463-707

Seoul National University Bundang Hospital, Seongnam-si

110-744

Seoul National University Hospital, Seoul

156-707

Seoul National University Boramae Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01580202 - Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine | Biotech Hunter | Biotech Hunter